NCT04603664View on ClinicalTrials.gov

Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Biochemical Markers ,NGAL,Cystatin c, Acute Kidneyinjury, Covid 19
Interventions
DIAGNOSTIC_TEST

serum NGAL and cystatin c

measuring serum NGAL and cystatin c on admission and after 48 hours in critically ill patients with covid 19 then compare results to serum creatinine and signs of acute kidney injury

Trial Locations (2)

11591

Ainshams hospitals, Cairo

11865

Sanaa Wasfy, New Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04603664 - Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection | Biotech Hunter | Biotech Hunter